Aflac stock

AFL · NYSE · USD

Compare Aflac
$127.69Change from previous close: −0.30%Absolute change: −$0.39

Close · November 17, 2026

Price history

+14.69% over the period

1 year: from $112.27 (November 17, 2025) to $128.76 (November 17, 2026), +14.69%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$128.76
October 30, 2026$123.89
September 30, 2026$111.78
August 31, 2026$115.85
July 31, 2026$127.48
June 30, 2026$117.25
May 29, 2026$112.42
April 30, 2026$113.67
March 31, 2026$109.71
February 27, 2026$112.93
January 30, 2026$110.95
December 31, 2025$110.27
November 28, 2025$110.31
November 17, 2025$112.27

At a glance

TickerLandia's take on Aflac

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$105.76
52-wk high$131.19

−2.67% from the 52-week high

Analysts · 15 analysts

Average target$119.80−6.18% vs. price

Buy 3 · Hold 8 · Sell 4 · Hold

TickerLandia Fingerprint: Aflac

Compared with similar companies: very low risk and very low growth.

Financials and price compared with 32 companies in the insurance - life industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Aflac is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Aflac's P/E today is 18.9, above the median of its last 10 fiscal years (10.7; between 6.67 and 16.2 from 2016 to 2025). Aflac's P/E (trailing 12 months): 18.6, +13% against the median of a group of 11 similar companies (16.5).

P/E compared with its history

Compared with 11 similar companies

Aflac's metrics compared with similar companies
MetricAflacPosition in the groupBand
P/E (trailing 12 months)18.6Middle
Forward P/E16.5High
ROE12.2%Low
Price/book2.16Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Aflac. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$4.12B

Latest quarter · Q2 2026

Net income

$825M

Latest quarter · Q2 2026

Quarterly net margin

20.0%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$63.12B
P/E
18.6
EPS
$6.85
Volume
1.73M
Daily trading
€201.92M
Dividend yield
2.37%

How Aflac is changing

All results
  • Revenue fell 5.0% a year on average over the last 5 years

  • Shares outstanding down 25.3% in 5 years

Returns

Aflac returns with dividends

$1,000 invested in Aflac 5 years ago, on November 17, 2021, would be worth $2,519 today with dividends reinvested: +151.86% in total, +20.29% per year. On price alone it would be $2,262 (+126.21%).

PeriodAflacS&P 500$1,000 becomes
1 month+8.50%−3.17%$1,085
6 months+9.31%+0.11%$1,093
Year to date+16.77%+8.34%$1,168
1 year+17.13%+11.15%$1,171
3 years+67.01%+64.30%$1,670
5 years+151.86%+58.18%$2,519
10 years+345.89%+239.10%$4,459

Over the last 6 months it has done better than 69% of the stocks in the Finance sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Aflac: technical analysis

Aflac is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 1.4% below its highest close since January 2, 1990 ($129.55, July 28, 2026).

Trend
Upward
RSI (14 sessions)
67
Between 30 and 70
vs 200-session average
+9.25%

Support and resistance

Price areas where Aflac has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$130.71+2.36%2 touches, last on November 5, 2026
  2. Last price$127.69
  3. Support$119.05−6.77%5 touches, last on September 16, 2026
  4. Support$116.44−8.81%2 touches, last on August 20, 2026
  5. Support$112.84−11.63%3 touches, last on September 10, 2026

Volatility and risk

Over the last year it has often moved in the opposite direction to the S&P 500.

Beta (1 year) vs S&P 500
−0.18
Volatility (60 sessions, annualised)
15.9%
Largest fall in the last year
−14.18%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Aflac: seasonality

Average monthly price change over 37 years

−0.5%Jan−0.0%Feb+1.9%Mar+4.4%Apr+0.8%May−1.2%Jun+3.6%Jul−0.7%Aug+1.0%Sep+3.6%Oct+2.5%Nov+1.8%Dec

Over the last 37 years, the strongest month for Aflac has been April: +4.38% on average, positive in 26 years out of 37. The weakest has been June: −1.21% on average, positive in 15 years out of 37. November, the current month, has been positive in 22 years out of 36 (+2.45% on average).

Show chart data
MonthAverageMedianPositive years
January−0.50%+0.88%21 of 36
February−0.02%+1.78%22 of 37
March+1.95%+1.57%21 of 37
April+4.38%+3.61%26 of 37
May+0.81%+0.69%21 of 37
June−1.21%−0.83%15 of 37
July+3.57%+3.33%25 of 37
August−0.74%+1.16%19 of 37
September+0.95%+0.91%21 of 37
October+3.63%+2.54%21 of 37
November+2.45%+2.24%22 of 36
December+1.83%+0.36%21 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Aflac and its competitors

Aflac Incorporated, based in Columbus, Georgia, has been operating since its founding in 1955. Through its subsidiaries it provides supplemental health and life insurance, with two reporting segments: Aflac Japan, which offers cancer, medical, nursing care, whole life and GIFT policies in Japan, and Aflac U.S., which covers accident, disability, dental, vision, hospital indemnity and life insurance in the United States. Its range also includes hearing, final expense, pet, Medicare supplement and short-term disability products.

Headquarters
Columbus, United States
Employees
12,716
Founded
1955
Chief executive
Daniel Amos
Aflac and its competitors
CompanyMarket capROEP/E (trailing 12 months)6 months
AflacAFL$63.12B12.2%18.6+9.31%
MetLifeMET$64.51B19.9%13.3+27.22%
Great-West LifecoGWO$58.72B14.4%19.3+21.58%
Manulife FinancialMFC$72.44B12.2%18.0+21.17%
Power Corporation of CanadaPOW$42.83B10.2%24.1+19.31%
Prudential FinancialPRU$40.35B12.0%10.6+20.02%

Same industry or related industries, similar size. Compare Aflac with its competitors · Full profile